Blue Water Life Science Advisors, LP Natera, Inc. Transaction History
Blue Water Life Science Advisors, LP
- $101 Million
- Q1 2025
A detailed history of Blue Water Life Science Advisors, LP transactions in Natera, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 208,494 shares of NTRA stock, worth $33.3 Million. This represents 29.22% of its overall portfolio holdings.
Number of Shares
208,494
Previous 254,794
18.17%
Holding current value
$33.3 Million
Previous $40.3 Million
26.9%
% of portfolio
29.22%
Previous 36.7%
Shares
15 transactions
Others Institutions Holding NTRA
# of Institutions
686Shares Held
126MCall Options Held
827KPut Options Held
1.14M-
Vanguard Group Inc Valley Forge, PA12.7MShares$2.03 Billion0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.5MShares$1.68 Billion0.18% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$1.18 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.08 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.55MShares$727 Million3.7% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $15.5B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...